CSIMarket


Alnylam Pharmaceuticals Inc   (ALNY)
Other Ticker:  
 

Alnylam Pharmaceuticals Inc

ALNY's Fundamental analysis








Looking into Alnylam Pharmaceuticals Inc growth rates, revenue grew by 54.82 % in I. Quarter 2024 from the same quarter a year ago. Ranking at No. 147

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -0.32 %

Alnylam Pharmaceuticals Inc net loss deacreased by in I. Quarter 2024 year on year, Alnylam Pharmaceuticals Inc net loss increased by -62.13 % in I. Quarter 2024 year on year,

More on ALNY's Growth


Alnylam Pharmaceuticals Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 1838.47 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 9.46.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.39.


More on ALNY's Valuation
 
 Total Debt (Millions $) 1,022
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 1,381,610
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 6.7
 Tangible Book Value (Per Share $) -1.74

Alnylam Pharmaceuticals Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 1838.47 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 9.46.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.39.


More on ALNY's Valuation

  Market Capitalization (Millions $) 18,951
  Shares Outstanding (Millions) 126
  Employees 1,450
  Revenues (TTM) (Millions $) 2,003
  Net Income (TTM) (Millions $) -332
  Cash Flow (TTM) (Millions $) 10
  Capital Exp. (TTM) (Millions $) -61
  Total Debt (Millions $) 1,022
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 1,381,610
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 6.7
  Tangible Book Value (Per Share $) -1.74

  Market Capitalization (Millions $) 18,951
  Shares Outstanding (Millions) 126
  Employees 1,450
  Revenues (TTM) (Millions $) 2,003
  Net Income (TTM) (Millions $) -332
  Cash Flow (TTM) (Millions $) 10
  Capital Exp. (TTM) (Millions $) -61





  Ratio
   Capital Ratio (MRQ) 3.17
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.57
  Inventory Turnover Ratio (TTM) 2.97





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com